MX2016009932A - Agente terapeutico o profilactico para esclerosis multiple. - Google Patents

Agente terapeutico o profilactico para esclerosis multiple.

Info

Publication number
MX2016009932A
MX2016009932A MX2016009932A MX2016009932A MX2016009932A MX 2016009932 A MX2016009932 A MX 2016009932A MX 2016009932 A MX2016009932 A MX 2016009932A MX 2016009932 A MX2016009932 A MX 2016009932A MX 2016009932 A MX2016009932 A MX 2016009932A
Authority
MX
Mexico
Prior art keywords
therapeutic
multiple sclerosis
prophylactic agent
active ingredient
present
Prior art date
Application number
MX2016009932A
Other languages
English (en)
Other versions
MX367576B (es
Inventor
TAKAGAKI Kozue
Kaino Mie
Hirokawa Hiroe
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of MX2016009932A publication Critical patent/MX2016009932A/es
Publication of MX367576B publication Critical patent/MX367576B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El propósito de la presente invención tiene es proporcionar un agente terapéutico o profiláctico para la esclerosis múltiple, que comprende un compuesto de bajo peso molecular no esteroideo como ingrediente activo. La presente invención proporciona un agente terapéutico o profiláctico para la esclerosis múltiple, que contiene, un derivado de ciclohexano como tipificado por un compuesto mostrado a continuación, o una sal farmacéuticamente aceptable del mismo como ingrediente activo. (ver Fórmula).
MX2016009932A 2014-01-29 2015-01-29 Agente terapéutico o profiláctico para esclerosis múltiple. MX367576B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014014063 2014-01-29
JP2014154893 2014-07-30
PCT/JP2015/052420 WO2015115509A1 (ja) 2014-01-29 2015-01-29 多発性硬化症の治療剤又は予防剤

Publications (2)

Publication Number Publication Date
MX2016009932A true MX2016009932A (es) 2017-01-11
MX367576B MX367576B (es) 2019-08-27

Family

ID=53757081

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016009932A MX367576B (es) 2014-01-29 2015-01-29 Agente terapéutico o profiláctico para esclerosis múltiple.

Country Status (8)

Country Link
US (2) US20170000767A1 (es)
EP (1) EP3100726A4 (es)
JP (1) JP6447496B2 (es)
CN (1) CN105934245B (es)
BR (1) BR112016016674A2 (es)
CA (1) CA2933018C (es)
MX (1) MX367576B (es)
WO (1) WO2015115509A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018181859A1 (ja) * 2017-03-31 2018-10-04 東レ株式会社 抗がん剤誘発末梢神経障害の治療剤又は予防剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02101065A (ja) * 1988-10-06 1990-04-12 Tanabe Seiyaku Co Ltd イミダゾリン誘導体及びその製法
JP2001114690A (ja) * 1999-08-06 2001-04-24 Takeda Chem Ind Ltd ｐ３８ＭＡＰキナーゼ阻害剤
EP1205478A4 (en) * 1999-08-06 2004-06-30 Takeda Chemical Industries Ltd P38MAP KINASE INHIBITORS
WO2008105383A1 (ja) 2007-02-26 2008-09-04 Toray Industries, Inc. ピラゾール誘導体およびその医薬用途
TWI435874B (zh) * 2008-10-31 2014-05-01 Toray Industries 環己烷衍生物及其醫藥用途
CN110269856A (zh) 2010-03-30 2019-09-24 维颂公司 多取代芳族化合物作为凝血酶的抑制剂
AU2011237074B2 (en) * 2010-03-31 2014-10-02 Toray Industries, Inc. Therapeutic agent or preventive agent for urine collection disorder
EP2554541B1 (en) 2010-03-31 2015-12-09 Toray Industries, Inc. Therapeutic agent or prophylactic agent for fibromyalgia
ES2560220T3 (es) * 2010-04-28 2016-02-17 Toray Industries, Inc. Agente terapéutico y agente preventivo para la enfermedad de Alzheimer
CA2805371C (en) 2010-07-30 2017-10-31 Toray Industries, Inc. Therapeutic agent or prophylactic agent for neuropathic pain

Also Published As

Publication number Publication date
EP3100726A4 (en) 2017-06-14
CA2933018A1 (en) 2015-08-06
US20170000767A1 (en) 2017-01-05
US10130608B2 (en) 2018-11-20
US20170231960A1 (en) 2017-08-17
BR112016016674A2 (pt) 2017-08-08
WO2015115509A1 (ja) 2015-08-06
CN105934245A (zh) 2016-09-07
CN105934245B (zh) 2019-04-09
JP6447496B2 (ja) 2019-01-09
CA2933018C (en) 2021-10-26
JPWO2015115509A1 (ja) 2017-03-23
MX367576B (es) 2019-08-27
EP3100726A1 (en) 2016-12-07

Similar Documents

Publication Publication Date Title
PH12018501099A1 (en) Novel biphenyl compound or salt thereof
PH12015502031A1 (en) Tetrahydropyrrolothiazine compounds
MX2017006266A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas al receptor de interleucina 1(irak) y sus usos.
MX2015003594A (es) Agente terapeutico o profilactico para sindrome de lisis tumoral.
PH12016502246A1 (en) Carboxamide derivatives
MX2020003020A (es) Compuestos de aminocarbonilcarbamato.
MX2016014946A (es) Derivados de carboxamida.
PH12018500903A1 (en) Pyranodipyridine compound
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
MX368496B (es) Análogos de compuestos de 4h-pirazolo[1,5-a]bencimidazol como inhibidores parp.
PH12019500370A1 (en) Triazolopyrazinone derivative useful as a human pde1 inhibitor
PH12017501336A1 (en) Preventive and/or therapeutic agent of immune disease
TW201613898A (en) Benzofuran analogue as NS4B inhibitor
MA39877A (fr) Formes solides d'un composé pharmaceutiquement actif
MX2016009932A (es) Agente terapeutico o profilactico para esclerosis multiple.
MX2016005539A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
EA201991269A1 (ru) Профилактический агент, агент, подавляющий начало заболевания, или терапевтический агент для прогрессирующих иммунных демиелинизирующих заболеваний
PH12019501027A1 (en) Therapeutic drug or prophylactic drug for diabetic nephropathy
MX2016013428A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
PH12016502247A1 (en) Carboxamide derivatives
IN2014MU00072A (es)
MA40320A (fr) Agent prophylactique ou thérapeutique pour des troubles du segment postérieur de l'œil
IN2014MU00070A (es)

Legal Events

Date Code Title Description
FG Grant or registration